MA59594B1 - Emplâtre médical à libération lente - Google Patents
Emplâtre médical à libération lenteInfo
- Publication number
- MA59594B1 MA59594B1 MA59594A MA59594A MA59594B1 MA 59594 B1 MA59594 B1 MA 59594B1 MA 59594 A MA59594 A MA 59594A MA 59594 A MA59594 A MA 59594A MA 59594 B1 MA59594 B1 MA 59594B1
- Authority
- MA
- Morocco
- Prior art keywords
- medical plaster
- slow release
- release medical
- plaster based
- release
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Plant Substances (AREA)
- Finger-Pressure Massage (AREA)
Abstract
L'invention concerne un emplâtre médical à libération lente, à base de diclofénac, en particulier un emplâtre médical à base de sel de sodium de diclofénac, dont la formulation permet la libération du principe actif en continu et à des concentrations localement actives sur le plan thérapeutique pendant 24 heures, ainsi que la matrice adhésive polymère (psa) destinée à être utilisée dans un emplâtre médical à base de sel de sodium de diclofénac.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102020000011686A IT202000011686A1 (it) | 2020-05-20 | 2020-05-20 | Cerotto medicato a lento rilascio |
| PCT/IB2021/054261 WO2021234562A1 (fr) | 2020-05-20 | 2021-05-18 | Emplâtre médical à libération lente |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA59594B1 true MA59594B1 (fr) | 2024-03-29 |
Family
ID=71994907
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA59594A MA59594B1 (fr) | 2020-05-20 | 2021-05-18 | Emplâtre médical à libération lente |
Country Status (36)
| Country | Link |
|---|---|
| US (1) | US20230190668A1 (fr) |
| EP (1) | EP4153151B1 (fr) |
| KR (1) | KR20230013033A (fr) |
| CN (1) | CN115666537B (fr) |
| AR (1) | AR122136A1 (fr) |
| AT (1) | AT525409A3 (fr) |
| BE (1) | BE1028251B1 (fr) |
| CA (1) | CA3178964A1 (fr) |
| CH (1) | CH718822B1 (fr) |
| CZ (1) | CZ2022461A3 (fr) |
| DE (1) | DE112021002871T5 (fr) |
| DK (2) | DK4153151T3 (fr) |
| EE (1) | EE05862B1 (fr) |
| ES (2) | ES2936185B2 (fr) |
| FI (1) | FI4153151T3 (fr) |
| FR (1) | FR3110397B1 (fr) |
| GB (1) | GB2610106B (fr) |
| GR (1) | GR1010304B (fr) |
| HR (1) | HRP20240192T1 (fr) |
| HU (2) | HU231555B1 (fr) |
| IE (1) | IE20210109A1 (fr) |
| IT (1) | IT202000011686A1 (fr) |
| LT (1) | LT4153151T (fr) |
| LU (1) | LU501245B1 (fr) |
| MA (1) | MA59594B1 (fr) |
| MD (1) | MD4153151T2 (fr) |
| NL (1) | NL2028233B1 (fr) |
| PL (2) | PL4153151T3 (fr) |
| PT (2) | PT4153151T (fr) |
| RO (1) | RO137440A2 (fr) |
| RS (1) | RS65194B1 (fr) |
| SI (1) | SI4153151T1 (fr) |
| SK (1) | SK289303B6 (fr) |
| SM (1) | SMT202400017T1 (fr) |
| TR (1) | TR2021008324A2 (fr) |
| WO (1) | WO2021234562A1 (fr) |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09208463A (ja) * | 1996-02-07 | 1997-08-12 | Tsumura & Co | 経皮吸収性に優れた消炎鎮痛組成物 |
| JP4181232B2 (ja) * | 1997-07-18 | 2008-11-12 | 帝國製薬株式会社 | ジクロフェナクナトリウム含有油性外用貼付製剤 |
| JP4865958B2 (ja) * | 2001-05-23 | 2012-02-01 | 株式会社トクホン | 鎮痛抗炎症局所作用型の貼付剤 |
| ATE529094T1 (de) * | 2003-01-27 | 2011-11-15 | Vitamin C60 Biores Corp | Zusammensetzung zur äusseren anwendung |
| CN1215838C (zh) * | 2003-06-25 | 2005-08-24 | 蚌埠丰原医药科技发展有限公司 | 双氯芬酸钠贴剂及其制备方法 |
| EP1807033B1 (fr) * | 2004-10-08 | 2016-07-20 | Noven Pharmaceuticals, Inc. | Dispositif d'administration transdermique de medicaments avec couche support occlusive |
| PT1877509E (pt) | 2005-03-17 | 2012-01-24 | Pharmafilm S R L | Sistema aquoso polimérico para a preparação de matriz de adesivo sensível à pressão |
| US20070259029A1 (en) * | 2006-05-08 | 2007-11-08 | Mcentire Edward Enns | Water-dispersible patch containing an active agent for dermal delivery |
| CN103384533A (zh) | 2010-12-29 | 2013-11-06 | 法玛费尔姆有限责任公司 | 双氯芬酸二乙铵的改进透皮渗透的药用贴剂 |
| EP2714019A1 (fr) * | 2011-05-26 | 2014-04-09 | Novartis AG | Compositions destinées à l'administration percutanée d'agents physiologiquement actifs |
| KR102009546B1 (ko) * | 2012-06-20 | 2019-08-09 | 히사미쓰 세이야꾸 가부시키가이샤 | 첩부제 |
| US9962349B2 (en) | 2014-10-17 | 2018-05-08 | Fidia Farmaceutici S.P.A. | Dermal therapeutic system with high adhesivity |
-
2020
- 2020-05-20 IT IT102020000011686A patent/IT202000011686A1/it unknown
-
2021
- 2021-05-11 GR GR20210100319A patent/GR1010304B/el active IP Right Grant
- 2021-05-18 LT LTEPPCT/IB2021/054261T patent/LT4153151T/lt unknown
- 2021-05-18 ES ES202290075A patent/ES2936185B2/es active Active
- 2021-05-18 NL NL2028233A patent/NL2028233B1/en active
- 2021-05-18 SK SK50056-2022A patent/SK289303B6/sk unknown
- 2021-05-18 CH CH001380/2022A patent/CH718822B1/it unknown
- 2021-05-18 SM SM20240017T patent/SMT202400017T1/it unknown
- 2021-05-18 PL PL21726205.4T patent/PL4153151T3/pl unknown
- 2021-05-18 HU HUP2200459A patent/HU231555B1/hu unknown
- 2021-05-18 CA CA3178964A patent/CA3178964A1/fr active Pending
- 2021-05-18 MD MDE20230333T patent/MD4153151T2/ro unknown
- 2021-05-18 US US17/925,515 patent/US20230190668A1/en active Pending
- 2021-05-18 DE DE112021002871.5T patent/DE112021002871T5/de active Pending
- 2021-05-18 PT PT217262054T patent/PT4153151T/pt unknown
- 2021-05-18 CZ CZ2022-461A patent/CZ2022461A3/cs unknown
- 2021-05-18 HR HRP20240192TT patent/HRP20240192T1/hr unknown
- 2021-05-18 EP EP21726205.4A patent/EP4153151B1/fr active Active
- 2021-05-18 WO PCT/IB2021/054261 patent/WO2021234562A1/fr not_active Ceased
- 2021-05-18 HU HUE21726205A patent/HUE066041T2/hu unknown
- 2021-05-18 GB GB2217015.3A patent/GB2610106B/en active Active
- 2021-05-18 RS RS20240130A patent/RS65194B1/sr unknown
- 2021-05-18 SI SI202130104T patent/SI4153151T1/sl unknown
- 2021-05-18 PL PL442805A patent/PL245596B1/pl unknown
- 2021-05-18 RO ROA202200733A patent/RO137440A2/ro unknown
- 2021-05-18 PT PT2021054261A patent/PT2021234562B/pt active IP Right Grant
- 2021-05-18 CN CN202180036277.8A patent/CN115666537B/zh active Active
- 2021-05-18 KR KR1020227040002A patent/KR20230013033A/ko active Pending
- 2021-05-18 EE EEP202200014A patent/EE05862B1/et unknown
- 2021-05-18 DK DK21726205.4T patent/DK4153151T3/da active
- 2021-05-18 LU LU501245A patent/LU501245B1/fr active IP Right Grant
- 2021-05-18 MA MA59594A patent/MA59594B1/fr unknown
- 2021-05-18 FI FIEP21726205.4T patent/FI4153151T3/fi active
- 2021-05-18 ES ES21726205T patent/ES2972189T3/es active Active
- 2021-05-18 AT ATA9160/2021A patent/AT525409A3/de unknown
- 2021-05-19 TR TR2021/008324A patent/TR2021008324A2/tr unknown
- 2021-05-19 FR FR2105212A patent/FR3110397B1/fr active Active
- 2021-05-19 IE IE20210109A patent/IE20210109A1/en unknown
- 2021-05-20 AR ARP210101380A patent/AR122136A1/es active IP Right Grant
- 2021-05-20 BE BE20215409A patent/BE1028251B1/fr active IP Right Grant
-
2022
- 2022-11-14 DK DKPA202201037A patent/DK181719B1/en active IP Right Grant
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2018201436B2 (en) | New therapeutic approaches for treating Parkinson's disease | |
| MX360289B (es) | Composiciones de tapentadol. | |
| ES2530719T3 (es) | Formulaciones de oxicodona para ser administradas una vez al día | |
| PA8748101A1 (es) | Benzoxazoles y oxazolopiridinas que son utiles como inhibidores de las cinasas janus | |
| DE60121301D1 (de) | Flibanserin zur Behandlung extrapyramidaler Bewegungsstörungen | |
| EP2572711A4 (fr) | Médicament antipaludéen qui contient de l'acide 5-aminolévulinique ou un dérivé en tant que principe actif | |
| AR063538A1 (es) | Tratamiento de la enfermedad de parkinson | |
| RU2012124268A (ru) | Бензимидазольные соединения и их применения | |
| HUE046320T2 (hu) | Eljárások tartós felszabadulású aminopiridin készítmények alkalmazására | |
| ECSP044986A (es) | Composicion farmaceutica que comprende lumiracoxib | |
| RU2008127882A (ru) | Лечение пищевода барретта | |
| DK1677777T3 (da) | Pellets indeholdende venlafaxin-hydrochlorid | |
| MA59594B1 (fr) | Emplâtre médical à libération lente | |
| JP2009242360A (ja) | 経口用の慢性疼痛予防または治療剤 | |
| UY31058A1 (es) | Formulaciones de aminoacido n-halogenado con compuestos antiinflamatorios | |
| BRPI0509271A (pt) | formas de dosagens farmacêuticas gastrorresistentes compreendendo ácido n-(2-(2-ftalimidaetóxi)-acetil-l-alanil-d-glutámico(lk-4 23) | |
| RU2353358C2 (ru) | Производные прегабалина для лечения приливов | |
| EA200701503A3 (ru) | Твердая пероральная лекарственная форма триметазидина дигидрохлорида с пролонгированным высвобождением, способ ее получения и способ лечения | |
| DOP2012000280A (es) | Combinación de un aine y un aminoacido | |
| JP5880913B2 (ja) | パーキンソン病の体幹症状（姿勢反射異常）の治療剤 | |
| MA34581B1 (fr) | Systèmes thérapeutiques transdermiques à feuille de protection inhibant la cristallisation (release liner) | |
| NO20064196L (no) | Utvortes preparat for behandling av smertefulle hudskader | |
| FR3116439B1 (fr) | Comprimé pelliculé contenant au moins un principe actif, adapté à l’administration par voie orale dudit au moins un principe actif chez des sujets humains | |
| Fredriksson et al. | Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa | |
| MX2025012194A (es) | Composicion farmaceutica oral, proceso para la produccion de granulos o una composicion farmaceutica oral, granulo farmaceutico oral, uso de la composicion farmaceutica y metodo para tratar afecciones inflamatorias, dolores y/o moderar el uso de opioides perioperatorios |